"Brain-drain" in an era of business and socio-economic uncertainty: the role of diversity training in managing social integration at the workplace. The case of Greece and Portugal

Purpose: This study examines the extent to which diversity training is being used in workplaces in the UK to better integrate migrant workers. The paper also aims at assessing the perceived challenges and benefits that diversity training may produce for individuals in an era of economic and social uncertainty and insecurity. The underlying reasons that made many highly-skilled individuals to emigrate would also be highlighted. Most importantly though, the paper aims at initiating a discussion as to what extent diversity training could facilitate their social integration at the workplace. Thus, to better serve its purpose, the study explores Greek and Portuguese migrant workers' perceptions of the phenomenon under investigation. Design/Methodology/Approach: Individuals who left Greece and Portugal for UK were identified as the target audience of this research. Due to time and access constraints, web-based social and professional networks proved to offer the best solution in accessing our sample population. The snowball technique was also utilised (recommendations from existing participants). For instance, Facebook was one amongst them by accessing various Greek and Portuguese community groups. Additionally, several professional sub-groups within Linkedin resulted to higher participation. Further to that, specific levels of integration were suggested (e.g. participants' intention to stay in the organisation, social support from British colleagues, type of diversity training programmes, psychological & work-related distress etc.) so to better evaluate the extent to which diversity training could facilitate their social integration at the workplace. So far, 56 people have successfully completed the survey questionnaire, yet with a response rate to be quite low compared to the members within the respective groups. Findings: Research evidence describes "brain-drain" as an intriguing and important issue both within the organisational and national contexts. The findings of this study indicate that crisis, low wages, and limited career advancement opportunities are amongst the most important reasons reported by respondents. On one hand, research participants reported an overall mediocre or inexistent diversity training programmes implemented within their workplaces. As a result, their social integration was difficult, with some participants indicating high levels of marginalisation within the workplace. In contrary, there were others suggesting that diversity training have offered them the social support being required to effectively integrate within the organisational and work settings. A large majority of our research participants outlined the importance of diversity training as a means of social integration at work. To this extent, the research could make a strong argument that diversity training can be viewed as a means to better integrate migrant workers at the workplace. Originality/Value: The research is expected to offer both theoretical and practical recommendations. The paper offers an association between the "social integration" paradigm and the institutional perspective by suggesting that the two elements of social integration at work (e.g. social connectedness & work context) can facilitate migrant workers’ social integration at work, while concurrently to eliminate its negative aspects. A brain-mobility process has dominated the headlines of most global media over the last 9-10 years, since the global financial crisis commenced. Final research findings and suggestions could constitute the starting point of future research within different national contexts; thus, to offer a comparison amongst people and nations over the phenomenon under investigation

Pulmonary Hypertension and Indicators of Right Ventricular Function.

Pulmonary hypertension (PH) is a rare disease, whose underlying mechanisms are not fully understood. It is characterized by pulmonary arterial vasoconstriction and vessels wall thickening, mainly intimal and medial layers. Several molecular pathways have been studied, but their respective roles remain unknown. Cardiac repercussions of PH are hypertrophy, dilation, and progressive right ventricular dysfunction. Multiple echocardiographic parameters are being used, in order to assess anatomy and cardiac function, but there are no guidelines edited about their usefulness. Thus, it is now recommended to associate the best-known parameters, such as atrial and ventricular diameters or tricuspid annular plane systolic excursion. Cardiac catheterization remains necessary to establish the diagnosis of PH and to assess pulmonary hemodynamic state. Concerning energetic metabolism, free fatty acids, normally used to provide energy for myocardial contraction, are replaced by glucose uptake. These abnormalities are illustrated by increased (18)F-fluorodeoxyglucose ((18)F-FDG) uptake on positron emission tomography/computed tomography, which seems to be correlated with echocardiographic and hemodynamic parameters

A Land-Use Approach for Capturing Future Trip Generating Poles

Changes in the usage of a particular urban or regional area have immediate effects on transportation, such as the development of a new multimodal terminal within a city, or the creation of a business park in its outskirts. Thus far, this correlation has been underresearched at a national level in Greece. As a result, its effects on trip generation and passenger flows has been underestimated at the planning level, leading to the implementation of projects that are neither viable nor sustainable. This paper proposes that land use changes ought to be considered in tandem with transport-related changes at the planning stage. To this effect, we present a three-step methodology for an integrated approach to capturing future trip generation: the identification of future trip-generating poles within the study area; the development of scenarios related to the probability of these changes occurring and their potential magnitude; an estimation of future trends in passenger flows. The methodology is applied to the Metropolitan area of Thessaloniki, Greece. Using data obtained from development plans, national statistical services and research projects’ and studies’ findings, we estimate future trip-generation subsequent to land use change. Data is processed and evaluated by a local experts’ group, representing various key-disciplines of the area’s planning stakeholders

Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease.

Integrin alpha-V-beta-3 (αvβ3) pathway is involved in intraplaque angiogenesis and inflammation and represents a promising target for molecular imaging in cardiovascular diseases such as atherosclerosis. The aim of this study was to assess the clinical correlates of arterial wall accumulation of <sup>68</sup> Ga-NODAGA-RGD, a specific α <sub>v</sub> β <sub>3</sub> integrin ligand for PET. The data of 44 patients who underwent <sup>68</sup> Ga-NODAGA-RGD PET/CT scans were retrospectively analyzed. Tracer accumulation in the vessel wall of major arteries was analyzed semi-quantitatively by blood-pool-corrected target-to-background ratios. Tracer uptake was compared with clinically documented atherosclerotic cardiovascular disease, cardiovascular risk factors and calcified plaque burden. Data were compared using the Mann-Whitney U test, Pearson correlation and Spearman correlation. <sup>68</sup> Ga-NODAGA-RGD arterial uptake was significantly higher in patients with previous clinically documented atherosclerotic cardiovascular disease (mean TBR 2.44 [2.03-2.55] vs. 1.81 [1.56-1.96], p = 0.001) and showed a significant correlation with prior cardiovascular or cerebrovascular event (r = 0.33, p = 0.027), BMI (ρ = 0.38, p = 0.01), plaque burden (ρ = 0.31, p = 0.04) and hypercholesterolemia (r = 0.31, p = 0.04). <sup>68</sup> Ga-NODAGA-RGD holds promise as a non-invasive marker of disease activity in atherosclerosis, providing information about intraplaque angiogenesis

First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK.

Integrin-targeting radiopharmaceuticals have potential broad applications, spanning from cancer theranostics to cardiovascular diseases. We have previously reported preclinical dosimetry results of (68)Ga-NODAGA-RGDyK in mice. This study presents the first human dosimetry of (68)Ga-NODAGA-RGDyK in the five consecutive patients included in a clinical imaging protocol of carotid atherosclerotic plaques. Five male patients underwent whole-body time-of-flight (TOF) PET/CT scans 10, 60 and 120 min after tracer injection (200 MBq). Quantification of (68)Ga activity concentration was first validated by a phantom study. To be used as input in OLINDA/EXM, time-activity curves were derived from manually drawn regions of interest over the following organs: brain, thyroid, lungs, heart, liver, spleen, stomach, kidneys, red marrow, pancreas, small intestine, colon, urinary bladder and whole body. A separate dosimetric analysis was performed for the choroid plexuses. Female dosimetry was extrapolated from male data. Effective doses (EDs) were estimated according to both ICRP60 and ICRP103 assuming 30-min and 1-h voiding cycles. The body regions receiving the highest dose were urinary bladder, kidneys and choroid plexuses. For a 30-min voiding cycle, the EDs were 15.7 and 16.5 μSv/MBq according to ICRP60 and ICRP103, respectively. The extrapolation to female dosimetry resulted in organ absorbed doses 17% higher than those of male patients, on average. The 1-h voiding cycle extrapolation resulted in EDs of 19.3 and 19.8 μSv/MBq according to ICRP60 and ICRP103, respectively. A comparison is made with previous mouse dosimetry and with other human studies employing different RGD-based radiopharmaceuticals. According to ICRP60/ICRP103 recommendations, an injection of 200 MBq (68)Ga-NODAGA-RGDyK leads to an ED in man of 3.86/3.92 mSv. For future therapeutic applications, specific attention should be directed to delivered dose to kidneys and potentially also to the choroid plexuses. Clinical trial.gov, NCT01608516

Evaluating the achievements and impacts of EC framework programme transport projects

Purpose The purpose of this paper is to present what kind of elements and evaluation methods should be included into a framework for evaluating the achievements and impacts of transport projects supported in EC Framework Programmes (FP). Further, the paper discusses the possibilities of such an evaluation framework in producing recommendations regarding future transport research and policy objectives as well as mutual learning for the basis of strategic long term planning. Methods The paper describes the two-dimensional evaluation methodology developed in the course of the FP7 METRONOME project. The dimensions are: (1) achievement of project objectives and targets in different levels and (2) research project impacts according to four impact groups. The methodology uses four complementary approaches in evaluation, namely evaluation matrices, coordinator questionnaires, lead user interviews and workshops. Results Based on the methodology testing, with a sample of FP5 and FP6 projects, the main results relating to the rationale, implementation and achievements of FP projects is presented. In general, achievement of objectives in both FPs was good. Strongest impacts were identified within the impact group of management and co-ordination. Also scientific and end-user impacts of the projects were adequate, but wider societal impacts quite modest. The paper concludes with a discussion both on the theoretical and practical implications of the proposed methodology and by presenting some relevant future research needs

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist (68)Ga-NODAGA-MJ9.

Gastrin-releasing peptide receptor antagonists have promise in theranostics of several highly incident tumours, including prostate and breast. This study presents the first human dosimetry of <sup>68</sup> Ga-NODAGA-MJ9 in the first five consecutive patients with recurrent prostate cancer included in a dual-tracer positron emission tomography (PET) protocol. Five male patients with biochemical relapse of prostate adenocarcinoma underwent four whole-body time-of-flight PET/CT scans within 2 h after tracer injection. To be used as input in OLINDA/EXM 2.0, time-integrated activity coefficients were derived from manually drawn regions of interest over the following body regions: brain, thyroid, lungs, heart, liver, gallbladder, spleen, stomach, kidneys, adrenals, red marrow, pancreas, intestines, urinary bladder and whole body. Organ absorbed doses and effective dose (ED) were calculated with OLINDA/EXM 2.0 using the NURBS voxelized phantoms adjusted to the ICRP-89 organ masses and ICRP103 tissue-weighting factors. Additional absorbed dose estimations were performed with OLINDA/EXM 1.1 to be comparable with similar previous publications. The body regions receiving the highest absorbed doses were the pancreas, the urinary bladder wall, the small intestine and the kidneys (260, 69.8, 38.8 and 34.8 μGy/MBq respectively). The ED considering a 30-min urinary voiding cycle was 17.6 μSv/MBq in male patients. The increment of voiding time interval produced a significant increase of absorbed doses in bladder, prostate and testes, as well as an increase of ED. ED also increased if calculated with OLINDA/EXM 1.1. These results have been discussed in view of similar publications on bombesin analogues or on other commonly used theranostic peptides. The pancreas is the most irradiated organ after the injection of <sup>68</sup> Ga-NODAGA-MJ9, followed by the urinary bladder wall, the small intestine and the kidneys. ED is in the same range of other common <sup>68</sup> Ga-labelled peptides. Differences with similarly published studies on bombesin analogues exist, and are mainly dependent on the methodology used for absorbed dose calculations. Clinicaltrial.Gov identifier: NCT02111954 , posted on 11/042014

Modify the redefined: strategic human resource development maturity at a crossroads

This integrative literature review reports on strategic human resource development (SHRD) models that examine the strategic embeddedness of HRD (SHRD maturity) in organizations. A review and critique of all existing SHRD models is provided, exemplifying their limitations and building upon their strengths to inform a modified SHRD framework. The latter suggests an enhanced set of strategic components to assess SHRD maturity. This paper further outlines how SHRD aspirations can be practiced within complex, dynamic, and continually changing business and economic environments. The SHRD literature is advanced by new insights on how HRD scholars and practitioners could assess and enhance the maturity of their HRD interventions in the context of constantly changing (dynamic) environments. The modified SHRD framework further contributes to the academic literature with its enhanced set of strategic characteristics, as well as with its SHRD pointers, all of which can offer a better evaluation of SHRD maturity during periods of business and economic complexity and uncertainty